Finerenone Treatment for Diabetic Cardiovascular Autonomic Neuropathy: the FibroCAN Study
Finerenone Treatment for Diabetic Cardiovascular Autonomic Neuropathy: the FibroCAN Study
Recruiting · NCT06906081 · Registry updated 2025-05-25Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Finerenone Treatment for Diabetic Cardiovascular Autonomic Neuropathy: the FibroCAN Study | Diabetes Complications, Nutritional and Metabolic Diseases, diabetes mellitus, diabetic neuropathy, endocrine system disorder, glucose metabolism disease, metabolic disease, nervous system disorder, neuromuscular disease, peripheral nervous system disorder, type 2 diabetes mellitus | Recruiting | Phase 2 | 2025-05-25 | NCT06906081 |
3 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Aarhus University Hospital | 297 |
| Peter Rossing | 2 |
| Steno Diabetes Center Nordjylland | 7 |
2 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Steno Diabetes Center Copenhagen | Herlev | Denmark | 18 |
| Steno Diabetes Center Northern Denmark | Gistrup | Denmark | 1 |